Assist. Prof. Dr Mohamed Rahamathulla | Pharmaceutical sciences | Best Researcher Award

Assist. Prof. Dr. Mohamed Rahamathulla holds a Ph.D. in Pharmaceutical Sciences and has 15 years of expertise in novel drug delivery systems, nanotechnology, and bioavailability enhancement. He currently serves as Assistant Professor at King Khalid University, Saudi Arabia. His research includes pharmaceutical formulation, biopharmaceutics, and chromatographic analysis. Dr. Rahamathulla has published over 65 research articles and secured significant research grants in drug delivery systems and cancer therapies. With his extensive contributions to the field, he is a strong contender for the Best Researcher Award. πŸ’ŠπŸ”¬πŸ“šπŸŒπŸ†

Assist. Prof. Dr Mohamed Rahamathulla, College of Pharmacy, KIng Khalid University, Saudi Arabia

Profile

GOOGLESCHOLAR

ORCID

SCOPUS

Education πŸŽ“

Assist. Prof. Dr. Mohamed Rahamathulla has a Ph.D. in Pharmaceutical Sciences from JNTU, Hyderabad (2016) πŸŽ“. He earned an M.Pharm in Pharmaceutics from Rajiv Gandhi University of Health Sciences, Bangalore (2005), with a 73% score πŸ’Š. Dr. Rahamathulla also holds a B.Pharm from the same university (2003), scoring 63% 🏫, and a D.Pharm from the Board of Examining Authority, Karnataka, with a 58% score πŸ“œ. Additionally, he completed a professional diploma in Intellectual Property Protection in Patents from the Indian Institute of Sciences, Bangalore, in July 2007 πŸ›‘οΈ.

ExperienceπŸ“šπŸŽ“

Dr. Mohamed Rahamathulla brings 15 years of academic and research experience in pharmaceutics. Currently serving as an Assistant Professor at King Khalid University, Abha, Saudi Arabia, since August 2022, he previously lectured there from 2015 to 2022. His expertise spans several institutions, including East West College of Pharmacy in Bangalore, India, where he was an Associate Professor, and Omar Mukhtar University in Libya, where he served as a Senior Lecturer. His career also includes teaching roles at Al Arab Medical University, Benghazi, and multiple colleges in India. πŸ“šπŸ”¬πŸŒ

Achievements πŸ…

Dr. Mohamed Rahamathulla has made significant contributions to research and education in pharmaceutics. He is the Principal Investigator (PI) for multiple large research projects funded by the Deanship of Research, including studies on novel drug delivery systems and anti-cancer drugs. He has also co-led projects on the quantification of Aloin and Aloe Vera in cosmetics, as well as antioxidant activity in arthritis drugs. His leadership extends to course development and student training, receiving recognition for his contributions to the Pharm D program. Additionally, he has served as a reviewer for notable pharmaceutical journals. πŸ”¬πŸ’‰πŸ“šπŸ‘¨β€πŸ”¬

Research Focus πŸ”¬

Assist. Prof. Dr. Mohamed Rahamathulla’s research focuses on advancing novel drug delivery systems (NDDS) and nanotechnology in cancer therapy 🧬. His work explores smart nanocarriers for targeted drug delivery, including applications in stomach and breast cancer therapies 🦠. Dr. Rahamathulla also investigates nanotechnology’s role in overcoming multidrug resistance in cancer treatments πŸ”¬. His research includes floating drug delivery systems, solid lipid nanoparticles for cancer and Alzheimer’s disease treatment 🧠, and microneedles for psoriasis management πŸ’‰. His expertise extends to pharmacokinetics, solubility enhancement, and bioavailability improvement in pharmaceutical formulations πŸ’Š.

Publications πŸ“š

“Epidermal growth factor receptors unveiled: a comprehensive survey on mutations, clinical insights of global inhibitors, and emergence of heterocyclic derivatives as EGFR inhibitors”

  • Authors: C, M., Pasha, T.Y., Rahamathulla, M., Shivanandappa, T.B., Pasha, I.
  • Journal: Journal of Drug Targeting (2025

“Sublingual Fast-Dissolving Thin Films of Loratadine: Characterization, In Vitro and Ex Vivo Evaluation”

  • Authors: Alhamhoom, Y., Said, A.K., Kumar, A., Ahmed, M.M., Shivanandappa, T.B.
  • Journal: Polymers (2024)

“Pregabalin solubility in supercritical green solvent: A comprehensive experimental and theoretical-intelligent assessment”

  • Authors: Gahtani, R.M., Talath, S., Hani, U., Rahamathulla, M., Khalid, A.
  • Journal: Journal of Molecular Liquids (2024)

“Lipid nanoparticles for blood brain barrier penetration”

  • Authors: Chopra, H., Munjal, K., Gauttam, V.K., Yadav, S., Rahamathulla, M.
  • Book: Lipid Based Nanocarriers for Drug Delivery (2024)

“Formulation and Evaluation of pH-Modulated Amorphous Solid Dispersion-Based Orodispersible Tablets of Cefdinir”

  • Authors: Alhamhoom, Y., Kumaraswamy, T., Kumar, A., Ahmed, M.M., Shivanandappa, T.B.
  • Journal: Pharmaceutics (2024)

“Simvastatin-Encapsulated Topical Liposomal Gel for Augmented Wound Healing: Optimization Using the Box-Behnken Model, Evaluations, and In Vivo Studies”

  • Authors: Rahamathulla, M., Pokale, R., Al-ebini, Y., Farhana, S.A., Shivanandappa, T.B.
  • Journal: Pharmaceuticals (2024)

“Box-Behnken Design-Based Optimization and Evaluation of Lipid-Based Nano Drug Delivery System for Brain Targeting of Bromocriptine”

  • Authors: K M, A.S., Angolkar, M., Rahamathulla, M., Osmani, R.A.M., Natarajan, J.
  • Journal: Pharmaceuticals (2024)
Assist. Prof. Dr Mohamed Rahamathulla | Pharmaceutical sciences | Best Researcher Award